Search
Showing results for "1"
News & Events
New study: Diabetes stress and coping strategiesThe Children’s Diabetes Centre is investigating the ways young people, and their primary carers, cope with stressors associated with type 1 diabetes.
Research
Trajectories of interparental conflict and children's emotional-behavioural functioning at 10-11 years: an Australian population-based studyInterparental conflict (IPC) has the potential to adversely affect children's social, emotional, and behavioural functioning. The overall objective of this study was to investigate the relationship between both the severity and chronicity of IPC across early and middle childhood and children's emotional-behavioural functioning at 10-11 years. Specifically, we aimed to: (1) identify distinct trajectories of IPC spanning 10-11 years since birth of the study child as reported by mothers, and (2) examine the emotional-behavioural functioning of children exposed to the identified IPC trajectories.
Research
New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individualsWe investigated immune and non-immune related genes to determine other factors required for the development of Abacavir hypersensitivity syndrome
Research
Effect of short-term use of a continuous glucose monitoring system with a real-timeThe objective of this study was to examine whether setting the low glucose alarm of a Guardian® REAL-Time continuous glucose monitoring system (CGMS) to 80 mg/d
News & Events
Research buddies make a differenceWhat is a research buddy and how you can be involved?
News & Events
Community involvement opportunity - Research BuddiesBecome a Research Buddy Ever wanted to be involved in type 1 diabetes research studies, but never knew how to get started or never had time before
News & Events
Understanding the relationship between insulin and carbsResearchers are on the hunt for young people with Type 1 Diabetes to participate in a short at-home trial looking at insulin and carbs.
Research
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 yearsWe report data from the interim analysis of the ongoing VIVIANE study, the aim of which is to assess the efficacy, safety, and immunogenicity of the HPV...
Research
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive CombinationsAntibodies that target immune checkpoints such as cytotoxic T lymphocyte antigen 4 (CTLA‐4) and the programmed cell death protein 1/ligand 1 (PD-1/PD-L1) are now a treatment option for multiple cancer types. However, as a monotherapy, objective responses only occur in a minority of patients. Chemotherapy is widely used in combination with immune checkpoint blockade (ICB). Although a variety of isolated immunostimulatory effects have been reported for several classes of chemotherapeutics, it is unclear which chemotherapeutics provide the most benefit when combined with ICB.